This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Fluzone

Sanofi

Drug Names(s): Fluzone ID, Flu ID, Preservative-free: Pediatric Dose, Influenza Virus Vaccine

Description: Fluzone is a sterile suspension prepared from influenza viruses propagated in embryonated chicken eggs, and is indicated for active immunization against influenza disease caused by influenza virus types A and B contained in thevaccine in subjects from 6 months of age and older. The original formulation for adults (Influenza Virus Vaccine Trivalent Types A and B, Zonal Purified, Subvirion) may have been approved by the FDA as early as the 1940's (actual date is uncertain). The intradermal form uses a very fine needle and is intended to take advantage of the greater number of immune cells in the dermis. Neither form of the vaccine is adjuvanted.

Please also see high dose Fluzone and Fluzone Quadrivalent.


Fluzone News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug